Skip to main content
Top

Cancer Causes & Control

Issue 1/2001

Content (10 Articles)

Chordoma: incidence and survival patterns in the United States, 1973–1995

Mary L. McMaster, Alisa M. Goldstein, Christina M. Bromley, Naoko Ishibe, Dilys M. Parry

A prospective study of obesity and cancer risk (Sweden)

Alicja Wolk, Gloria Gridley, Malin Svensson, Olof Nyrén, Joseph K. McLaughlin, Joseph F. Fraumeni, Hans-Olov Adami

Peanut butter intake, GSTM1 genotype and hepatocellular carcinoma: a case–control study in Sudan

Ragaa E. Omer, Linda Verhoef, Pieter Van't Veer, Mohamed O. Idris, Abdelgadir M.Y. Kadaru, Ellen Kampman, Annelies Bunschoten, Frans J. Kok

Public awareness of warning signs for cancer in Britain

N. Brunswick, J. Wardle, M.J. Jarvis

A population-based case–control study of carotenoid and vitamin A intake and ovarian cancer (United States)

Elizabeth R. Bertone, Susan E. Hankinson, Polly A. Newcomb, Bernard Rosner, Walter C. Willett, Meir J. Stampfer, Kathleen M. Egan

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine